RXST icon

RxSight
RXST

Overview Fund Activity

53 hedge funds and large institutions have $94.9M invested in RxSight in 2022 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 25 increasing their positions, 12 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
53
Holders Change
+4
Holders Change %
+8.16%
% of All Funds
0.92%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
25
Reduced
12
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Point72 Asset Management
1
Point72 Asset Management
Connecticut
$2.85M
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$9.63M
3
Geode Capital Management
3
Geode Capital Management
Massachusetts
$3.36M
4
PHP
4
Parkman Healthcare Partners
Connecticut
$2M
5
BlackRock
5
BlackRock
New York
$11.8M

Top Sellers

1
EI
1
EAM Investors
California
$0
2
RI
2
RTW Investments
New York
$0
3
EGI
3
EAM Global Investors
California
$0
4
BM
4
Bridger Management
New York
$2.66M
5
SC
5
Sessa Capital
New York
$1.63M
Name Holding Trade Value Shares
Change 		Shares
Change %
Royal Bank of Canada
51
Royal Bank of Canada
Ontario, Canada
$3K +$1.61K +135 +116%
Fidelity Investments
52
Fidelity Investments
Massachusetts
$2K +$10 +1 +0.5%
CS
53
Credit Suisse
Switzerland
$1K +$835 +96 +505%
EI
54
EAM Investors
California
– -$2.48M -176,270 Closed
RI
55
RTW Investments
New York
– -$2.11M -150,000 Closed
EGI
56
EAM Global Investors
California
– -$1.4M -99,317 Closed
AllianceBernstein
57
AllianceBernstein
Tennessee
– -$242K -17,194 Closed
1 2
3